Cargando…

Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial

OBJECTIVE: The present study is a phase I/IIa non-randomized, open-label study to evaluate safety and efficacy of a single, intravenous infusion of autologous, adipose-derived mesenchymal stem cells (adMSCs) over a period of 52 weeks, in patients with active rheumatoid arthritis (RA). METHODS: 15 el...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vij, Ridhima, Stebbings, Kevin A., Kim, Hosu, Park, Hyeonggeun, Chang, Donna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896321/ https://www.ncbi.nlm.nih.gov/pubmed/35241141 http://dx.doi.org/10.1186/s13287-022-02763-w

Ejemplares similares

Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program
por: Vij, Ridhima, et al.
Publicado: (2023)

Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report
por: Vij, Ridhima, et al.
Publicado: (2023)

Frequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case report
por: Vij, Ridhima, et al.
Publicado: (2022)

Disease activity and cognition in rheumatoid arthritis: an open label pilot study
por: Raftery, Graham, et al.
Publicado: (2012)

Antioxidant intervention in rheumatoid arthritis: results of an open pilot study
por: van Vugt, Richard M., et al.
Publicado: (2008)

Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxins: results of an open-labelled pilot study
por: Katayama, Kou, et al.
Publicado: (2011)

Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
por: Scordo, Michael, et al.
Publicado: (2022)

An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability
por: Sharma, Alok, et al.
Publicado: (2018)

Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation
por: Peng, Qiuwei, et al.
Publicado: (2023)

Autologous adipose-derived stem cells for the treatment of Crohn’s fistula-in-ano: an open-label, controlled trial
por: Zhou, Chungen, et al.
Publicado: (2020)

Measuring the impact of an educational intervention in rheumatoid arthritis: An open-label, randomized trial
por: Michou, Laëtitia, et al.
Publicado: (2021)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2023)

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
por: Rodriguez, Jorge Paz, et al.
Publicado: (2012)

Autologous adipose-derived mesenchymal stem cell therapy reverses detrusor underactivity: open clinical trial
por: Coelho, Henrique Rodrigues Scherer, et al.
Publicado: (2023)

An Open-Label Pilot Study to Assess the Efficacy and Safety of Virgin Coconut Oil in Reducing Visceral Adiposity
por: Liau, Kai Ming, et al.
Publicado: (2011)

Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study
por: Ho, Ling Yin, et al.
Publicado: (2007)

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
por: Cohen, Stanley, et al.
Publicado: (2019)

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
por: Burmester, Gerd R, et al.
Publicado: (2019)

Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis.
por: Kim, Ki Chan, et al.
Publicado: (2002)

Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI
por: Ruppert, Katherine A., et al.
Publicado: (2020)

Safety of Intraperitoneal Injection of Adipose Tissue‐Derived Autologous Mesenchymal Stem Cells in Cats
por: Parys, M., et al.
Publicado: (2016)

Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial
por: Lim, Jaejoon, et al.
Publicado: (2021)

Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating β-arrestin 2
por: Tang, Jing, et al.
Publicado: (2019)

Correction: Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI
por: Ruppert, Katherine A., et al.
Publicado: (2021)

Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study
por: Fleischmann, Roy, et al.
Publicado: (2018)

Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study
por: Fleischmann, Roy, et al.
Publicado: (2018)

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
por: Chatzidionysiou, Katerina, et al.
Publicado: (2016)

Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East
por: Hammoudeh, Mohammed, et al.
Publicado: (2015)

Autologous chondrocyte implantation for rheumatoid arthritis of the knee: a case report
por: Kim, Seok-Jung, et al.
Publicado: (2009)

Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
por: Hamidou, Mohamed, et al.
Publicado: (2021)

A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial
por: Stanislaus, Vimal, et al.
Publicado: (2023)

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status
por: van der Bijl, Arie E., et al.
Publicado: (2008)

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study
por: Isaacs, John D, et al.
Publicado: (2019)

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study
por: Genovese, Mark C., et al.
Publicado: (2019)

Efficacy of Vitamin E in Methotrexate-Induced Hepatotoxicity in Rheumatoid Arthritis: An Open-Label Case-Control Study
por: Vaidya, Binit, et al.
Publicado: (2020)

Role of inflammatory factors and adipose tissue in pathogenesis of rheumatoid arthritis and osteoarthritis. Part I: Rheumatoid adipose tissue
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial
por: Granel, Brigitte, et al.
Publicado: (2015)

Mesenchymal stem cells, autoimmunity and rheumatoid arthritis
por: El-Jawhari, J.J., et al.
Publicado: (2014)

In vitro autoreactivity against autologous keratinocytes in patients with rheumatoid and juvenile idiopathic arthritis
por: Štechová, K, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_a1tvdi7ia4ntv3cba3j41k2r93